BDBM50169897 3-{4-[4-Amino-6-(3-chloro-phenylamino)-[1,3,5]triazin-2-yl]-pyridin-2-ylamino}-propan-1-ol::CHEMBL190805

SMILES Nc1nc(Nc2cccc(Cl)c2)nc(n1)-c1ccnc(NCCCO)c1

InChI Key InChIKey=GASCNUBLHQPAMW-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50169897   

TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50169897(3-{4-[4-Amino-6-(3-chloro-phenylamino)-[1,3,5]tria...)
Affinity DataIC50:  1.07E+3nMAssay Description:Inhibition of vascular endothelial growth factor receptor 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50169897(3-{4-[4-Amino-6-(3-chloro-phenylamino)-[1,3,5]tria...)
Affinity DataIC50:  1.11E+3nMAssay Description:Inhibition of cyclin dependent kinase (CDK1)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed